MRSA Compensation Ireland: When Can You Claim for a Hospital-Acquired Infection?

Gary Matthews, personal injury and medical negligence solicitor, Dublin

Reviewed for legal accuracy by Gary Matthews, Personal Injury & Medical Negligence Solicitor. Law Society of Ireland PC No. S8178. 01 9036408.

Gary Matthews, personal injury and medical negligence solicitor, Dublin

About the author: Gary Matthews, Personal Injury & Medical Negligence Solicitor

Gary Matthews is one of the personal injury solicitors in Dublin at this firm, serving clients across Ireland. He qualified as a solicitor in 1992, established his firm in 1995, and has concentrated on personal injury and medical negligence litigation since 1997. He is a practising solicitor regulated by the Law Society of Ireland (practising-certificate no. S8178), which can be confirmed by searching his name on the Law Society's Find a Solicitor register.

Request a Callback

Or Call Us Now at 01 9036408

Name(Required)

Quick answer: An MRSA compensation claim in Ireland is a medical negligence personal injury claim seeking damages for an MRSA infection that a hospital, through a failure in infection prevention and control, caused or failed to treat properly. You may be able to claim compensation for MRSA caught in an Irish hospital, but only where the infection resulted from a failure to meet the required standard of infection prevention and control, not simply because you contracted MRSA. This page explains MRSA compensation Ireland claims in full: an MRSA hospital negligence claim is a type of personal injury claim brought as medical negligence, which means it bypasses the Injuries Resolution Board (IRB) and proceeds directly through the courts on the strength of an independent expert report. To succeed you must prove two things: that the hospital breached its duty of care, and that the breach (rather than the ordinary, unavoidable risk of surgery) caused your infection.

Answer card: MRSA in hospital is not automatic negligence. A claim needs a breach of infection-control duty measured against the Dunne standard and HPSC national guidance, plus proof the breach caused the infection (the exogenous-versus-endogenous question). Time limit: two years, though the O'Sullivan v Ireland [2019] IESC 33 date-of-knowledge rule can move when that clock starts. General damages are mapped from Personal Injuries Guidelines proxy brackets, and the 2021 figures still apply.

Contents

MRSA claims in Ireland at a glance

Legal test for the standard of care: Dunne v National Maternity Hospital [1989] IR 91, asking whether a competent body of peers would have acted the same way.

Causation test: the "but-for" test, on the balance of probabilities (51%+). Our guide to causation in medical negligence explains the alternatives.

Key MRSA precedent: O'Sullivan v Ireland [2019] IESC 33 (Supreme Court), on when the time-limit clock starts for a latent hospital infection.

Time limit: two years from the date of knowledge. See medical negligence time limits.

Route: medical negligence, straight to court, not the Injuries Resolution Board.

Expert needed: an independent consultant microbiologist or infection-control physician.

Can you claim compensation for MRSA caught in an Irish hospital?

Yes, but a successful MRSA claim depends on negligence, not on the infection alone. Irish hospitals are not insurers against every harm. MRSA can be contracted even where infection-control practice is flawless, and the law recognises that. The Supreme Court put it plainly in the leading MRSA case, noting that an MRSA infection can be caught in a hospital without any negligence on anyone's part [1]. The real question is therefore never simply whether you got MRSA in hospital. It is whether a failure in your care caused the MRSA, or made it materially more likely.

That distinction is the whole case. To bring an MRSA infection compensation claim in Ireland you have to establish two separate things, and the second is usually harder than the first. The table below sets them out.

The two elements of an MRSA medical negligence claim in Ireland.
ElementWhat you must show
Breach of dutyThe hospital, its management, or its staff failed to meet the standard of infection prevention and control that a competent body of peers would have met. The benchmark is the Dunne standard, measured against national infection-control guidance.
CausationThat breach, rather than the ordinary unavoidable risk of treatment, caused your infection or made a material contribution to it. This is where MRSA cases are won and lost.

Because this is medical negligence rather than a standard personal injury claim, it does not go through the Injuries Resolution Board. It proceeds directly to litigation, and the courts have confirmed it is not appropriate to issue proceedings without a supportive report from an independent medical expert. Understanding how that proof works, and how long you have to act, is what lets you decide whether pursuing compensation for an injury like this is realistic in your own situation, which is what the rest of this guide is for.

What is MRSA, and why catching it isn't automatically negligence

MRSA stands for meticillin-resistant Staphylococcus aureus, a strain of a common skin bacterium that has become resistant to the standard penicillin-type antibiotics, including flucloxacillin and the cephalosporins [2]. It is not a single illness so much as an organism that becomes dangerous in the wrong place. Many healthy people carry Staphylococcus aureus, sometimes MRSA, harmlessly on the skin or in the nose. This carriage state is called colonisation, and on its own it causes no symptoms and is not an injury.

The problem arises when MRSA breaches the body's defences through a surgical wound, a drip or cannula site, a urinary catheter, a central line, an ulcer, or a pressure sore. Once it reaches the bloodstream or deep tissue it can cause serious infections: bloodstream infection (bacteraemia or septicaemia), pneumonia, infection of the heart valves (endocarditis), and bone or joint infection [3]. Because the organism resists frontline antibiotics, doctors are left with a narrow range of treatments, typically intravenous vancomycin or teicoplanin, which themselves require careful monitoring.

Why this matters legally: because so many people are already colonised, the mere presence of MRSA does not prove where or how it was acquired. A patient may have carried MRSA into hospital, picked it up in the community, or acquired it on the ward. Untangling those possibilities is the central evidential task in any MRSA claim, and it is why an infection on its own is never enough.

This is the single most important point on this page, and the reason most generic content gets MRSA claims wrong. An infection is not the same as negligence. Infections are a recognised, sometimes unavoidable, risk of hospital treatment. A claim exists only where the infection resulted from a failure to meet the required standard of care, and where that failure can be shown to have caused the harm. Everything that follows is about telling those two situations apart.

MRSA symptoms and warning signs after hospital treatment

MRSA usually shows itself first at a wound or device site, then through signs that the infection has spread. Spotting it early matters clinically and legally, because a delay in recognising and treating MRSA is one of the situations that can turn an infection into a claim. If you notice any of these after a hospital stay, seek medical attention promptly and ask whether you should be tested for MRSA.

At a surgical wound, a cannula or drip site, a catheter, or a pressure sore, the local warning signs include increasing redness, swelling, heat, and pain, pus or unusual discharge, a wound that will not heal or that reopens, and red streaking spreading from the site. When MRSA reaches the bloodstream or deeper tissue, the wider signs can include a high temperature and chills, feeling generally very unwell, breathlessness, a fast heartbeat, dizziness or confusion, and the features of sepsis [3]. Some MRSA infections become systemic and life-threatening, which is why sepsis arising from a hospital infection is treated as its own serious route to a claim, covered on our sepsis misdiagnosis page.

Recognising these signs is about your safety first. Whether a claim exists is a separate legal question that depends on whether the infection, or a delay in treating it, resulted from a failure in your care. The point for a possible claim is timing: if you raised clear symptoms and they were not acted on, the dates and what you were told can become important evidence, so it helps to note them.

Common points where MRSA enters the body in hospital A simple schematic showing the usual routes by which MRSA breaches the body's defences in a hospital setting: a surgical wound, a cannula or drip site, a urinary catheter, a central line, and a pressure sore. The diagram is non-clinical and for orientation only. Where MRSA commonly breaches the body's defences Surgical wound Cannula or drip site Urinary catheter Central line Pressure sore
MRSA carried harmlessly on the skin becomes dangerous when it crosses one of these routes into the bloodstream or deep tissue. The schematic is for orientation only and is not medical advice.

When MRSA becomes negligence: the Dunne test and HPSC standards

MRSA becomes negligence when the hospital departs from the accepted standard of infection prevention and control in a way that a responsible body of peers would not have, and that departure harms the patient. In Irish law the standard of care in any medical negligence case comes from the Supreme Court's decision in Dunne v National Maternity Hospital [1989] IR 91, the principles of which were reaffirmed by the Supreme Court in Morrissey v HSE [2020] IESC 6 [1]. In short, a hospital or clinician is negligent only where guilty of a failure no practitioner of equal status, acting with ordinary care, would be guilty of.

Applied to MRSA, the "general and approved practice" against which that failure is measured has a named source in Ireland: Prevention and Control of Meticillin-Resistant Staphylococcus aureus (MRSA), National Clinical Guideline No. 2, issued by the Health Protection Surveillance Centre (HPSC) in 2013 under the HSE [2]. This sits within the broader national framework set by the NCEC National Clinical Guideline No. 30 on Infection Prevention and Control, published in 2023 and updated in 2025, which governs infection prevention across Irish healthcare [10]. Most competitor pages refer only to "HSE protocols" in general terms, yet a claim typically turns on proving a clear, indefensible departure from this guidance. The kinds of failure that can ground an MRSA claim are set out below.

Infection-control failures that can ground an MRSA claim, applied to MRSA specifically.
Type of failureHow it applies to MRSA
Screening failuresNational Clinical Guideline No. 2 uses targeted screening, swabbing patients identified as high-risk rather than every admission. The clinical reason is stark: a large proportion of carriers are missed if staff wait to swab a wound only once it looks infected. Failing to screen a high-risk patient who should have been screened can let an unrecognised carrier enter a ward and seed an outbreak.
Hand-hygiene and PPE failuresMRSA spreads mainly from person to person, usually on the contaminated hands of staff or via contaminated equipment and surfaces. A failure to follow hand-hygiene protocol between patients, or to use gloves and aprons appropriately, is a recognised basis for liability.
Isolation and decolonisation failuresThe guideline requires that patients found to carry or be infected with MRSA are informed promptly, started on decolonisation where appropriate, and isolated or cohorted to stop transmission. A point that matters legally: decolonisation aims at temporary suppression of the organism rather than complete eradication, so the standard is whether the protocol was correctly followed, not whether the patient was cleared of MRSA. Failing to isolate a known MRSA-positive patient on a ward of vulnerable patients is a documented governance failure.
Negligent delay in diagnosis or treatmentLiability often arises not from the infection itself but from a delay in recognising it, by failing to take timely blood cultures or wound swabs, or prescribing ineffective antibiotics when MRSA-specific treatment was needed.
Administrative and overcrowding contextOvercrowding does not by itself prove negligence, but where vulnerable surgical patients are placed on trolleys in escalation areas with isolation and spacing compromised, that context can support a breach case. Independent HIQA inspection reports documenting deficiencies in governance, staffing, or infection control are frequently used to establish the clinical setting [4].

This page deals with how those breaches play out specifically for MRSA. The general anatomy of an infection-control breach, including the recognised categories, the discovery requests each one needs, and the surveillance data behind them, is set out separately in our guide to infection control failures, which the MRSA analysis here is designed to sit alongside rather than repeat. For the wider duty owed by a hospital, see our guide to hospital negligence claims.

A published Irish outbreak shows why following the protocol is the test, not the outcome. In a four-year MRSA outbreak in a surgical high-dependency unit, the unit's usual control measures were in place, two staff were found to carry the outbreak strain, and even after successful decolonisation, recolonisation and further transmission to patients occurred [8]. Whole-genome sequencing tied the cases together, which is the kind of evidence that can prove a single source. The same study illustrates the defence point in reverse: transmission can happen despite reasonable care, so the existence of an outbreak does not, by itself, establish negligence.

MRSA is common, but that does not make a claim easier. A rising background rate is context, not proof of fault. National surveillance recorded MRSA at 10.7% of invasive Staphylococcus aureus bloodstream isolates in 2024, up from 9.6% in 2023 [9]. That figure helps show MRSA is a known, foreseeable risk that hospitals must manage, which supports the duty side of a claim. It does not prove your own infection was caused by a breach, and the wider picture of infection-control failures is covered on our infection control failures page.

The 48-hour point, handled carefully: you will often read that an infection appearing more than 48 hours after admission is treated as hospital-acquired. That is a clinical and surveillance definition used to classify infections. It is not, in itself, a legal test of negligence, and it does not prove the hospital was at fault. It can be a useful starting indicator of where an infection was acquired, but the legal questions of breach and causation still have to be answered separately.

Exogenous versus endogenous MRSA: the causation battleground

The hardest part of an MRSA claim is proving that the hospital's breach caused the infection. Irish courts apply the "but-for" test, asking whether, but for the negligent act or omission, you would have avoided the injury, on the balance of probabilities (more than 50% likely). In MRSA cases the defence rarely disputes that infections happen. It disputes where this one came from. The argument almost always reduces to a single distinction.

Exogenous versus endogenous MRSA acquisition and its effect on liability Two routes. Exogenous: MRSA passes from an external source such as staff hands or equipment to the patient, which points toward a lapse in care. Endogenous: MRSA moves from the patient's own existing carriage to their own wound, which the defence argues is not readily preventable. Exogenous (external source) MRSA passes TO the patient from outside Staff hands / equipment Patient Points toward a lapse in care, supports liability Endogenous (patient's own flora) MRSA moves from the patient to their own wound Patient's own carriage Own wound Defence: not readily preventable, disputes liability
How MRSA was acquired largely decides whether the hospital is liable. Establishing the route is the core job of the plaintiff's microbiology expert.

Exogenous transmission means the MRSA came from an external source, most often a healthcare worker's contaminated hands, or contaminated equipment or surfaces. Because this route is preventable by proper hand hygiene, screening, and isolation, exogenous acquisition points toward a lapse in the standard of care.

Endogenous transmission means the patient was already carrying MRSA, and it travelled from their own nose or skin to their own surgical wound. The defence argues that this self-infection is not readily preventable by ordinary contact precautions, and therefore implies no negligence. Defendants also commonly argue that the patient acquired MRSA in the community before admission, or in a nursing home after discharge, breaking the chain of causation back to the acute hospital. There is a real microbiological basis for that argument, because community-associated MRSA strains differ from the hospital-associated strains that circulate in wards. Strain typing can cut both ways here: it can support the community-acquisition defence, or it can defeat it by matching the patient's strain to a hospital outbreak.

Defeating those arguments requires a detailed, supportive liability report from an independent expert, usually a consultant microbiologist or infection-control physician, whose task is to identify the source of the infection on the balance of probabilities. In stronger cases this can involve genomic typing, showing that the specific strain of MRSA isolated from the patient's wound matches an outbreak strain circulating on the ward at the time, which is powerful evidence that the hospital's breach introduced the organism. Where the strict but-for link is genuinely hard to draw, Irish law also recognises a material contribution route in some circumstances, where the breach made a more than negligible contribution to the risk of infection. How those proof routes are chosen and instructed is set out in our guide to causation in medical negligence.

In our experience handling these files, the single biggest practical hurdle is obtaining timely, independent microbiology evidence capable of distinguishing exogenous from endogenous acquisition. The earlier that expert is instructed, the more of the contemporaneous evidence, such as swab results, ward surveillance, and isolation records, is still available to work with.

Time limits and the O'Sullivan date-of-knowledge rule

The general time limit for a medical negligence claim in Ireland is two years. For MRSA, though, the date that clock starts is often the decisive issue, because the infection, and the realisation that it might be down to negligence rather than bad luck, can emerge well after the hospital stay. The two-year period is set by section 3(1) of the Statute of Limitations (Amendment) Act 1991, as amended through Part 2A of the Civil Liability and Courts Act 2004 and substituted by section 221 of the Legal Services Regulation Act 2015, and the "date of knowledge" construction that fixes when the clock starts is in section 2 of the 1991 Act [5], with the leading authority an MRSA case.

It is two years in Ireland, not three. Several MRSA pages that appear in Irish search results quote a three-year limit. That is the position in the United Kingdom under its Limitation Act 1980, and it does not apply here. In the Republic of Ireland the period is two years from the date of knowledge. A longer, three-year period for clinical negligence actions was provided for by section 221 of the Legal Services Regulation Act 2015, which substituted a new section 3(1) into the Statute of Limitations (Amendment) Act 1991, but that three-year clinical-negligence period is conditional on the introduction of pre-action protocols and has never been commenced, so as things stand the limit remains two years [5]. Relying on the UK figure can cost you the final year of your actual deadline.

O'Sullivan v Ireland [2019] IESC 33, the MRSA limitation case

Mr O'Sullivan contracted MRSA during an operation at the Bon Secours Hospital in Cork in September 2005, and was told in October 2005 that he had a hospital-acquired MRSA infection. His solicitor obtained his hospital records during 2006, and a preliminary expert report linking the infection to a potential systemic failure in care arrived in February 2007. He issued his summons in August 2008. The hospital argued the claim was out of time, counting two years from the infection. By a four-to-one majority, the Supreme Court disagreed: simply knowing you have a hospital infection is not the same as knowing it is attributable to negligence [1]. The court held that the limitation clock is not triggered until the plaintiff has that broad knowledge of the relevant acts or omissions, which here came no earlier than the expert material, provided the plaintiff acted reasonably promptly in seeking expert advice.

Date-of-knowledge timeline in O'Sullivan v Ireland A timeline of the O'Sullivan case. The infection was contracted in September 2005 and disclosed in October 2005. Medical records arrived in July 2006 and a preliminary expert report in February 2007. The summons issued in August 2008. Counted naively from the September 2005 infection, the two-year limit would have expired in September 2007 and the claim would be out of time. Counted from the date of knowledge linked to the expert report, the claim was in time. O'Sullivan v Ireland: when did the two-year clock start? Sep 2005 Infection during surgery Oct 2005 Told he had MRSA Jul 2006 Records obtained Feb 2007 Expert report: clock starts Aug 2008 Summons issued Naive clock from infection: 2 years would end Sep 2007, out of time Date-of-knowledge clock from the expert report: claim in time when issued in 2008
The infection happened in 2005, but the Supreme Court held the two-year clock did not start until the plaintiff had the knowledge, linked to the expert report, that the infection was attributable to negligence.

The practical effect is significant. An MRSA claim may not be statute-barred even though the infection itself happened years ago, provided you took reasonable steps to obtain the expert advice needed to connect it to negligence. Two important cautions go with that, so it is not misread.

  • O'Sullivan is a limitation ruling, not a finding of negligence. The Supreme Court decided only that the claim could proceed in time. Liability was contested and never decided in that judgment. The case tells you when the clock starts, not that a hospital was at fault.
  • It is not a licence to wait. The protection depends on acting reasonably. The most common way valid claims are lost is by waiting passively while the two-year window runs. Once you suspect something went wrong, the clock may already be running.

One detail of O'Sullivan is easy to miss and worth drawing out: Bon Secours Cork is a private hospital, which decides who you actually claim against. In a private-hospital MRSA case the defendant is the hospital and its insurer. In a public, HSE-run hospital, claims are managed by the State Claims Agency under the Clinical Indemnity Scheme. The proof you need is the same, but the opponent and the correspondence differ, as explained in our guide to hospital negligence claims. There is also a route by which the clock can start later than the hospital stay. If an MRSA outbreak comes to light through a mandatory open-disclosure meeting, the facts disclosed at that meeting may give you the knowledge that starts your two-year clock, a point covered in our guide to medical negligence time limits.

Missing the limitation period removes your right to pursue compensation for the injury however strong the underlying claim, which is why date of knowledge in infection cases deserves careful, early analysis. We cover the four-part knowledge test and the contrasting case law in detail in our guides to date of knowledge in medical negligence and medical negligence time limits. Special situations, such as claims for children or on behalf of someone who has died, run on different clocks and should be checked individually.

How much compensation can you get for MRSA in Ireland?

Compensation for a successful MRSA claim is assessed under two headings: general damages for pain, suffering, and loss of amenity, and special damages for financial losses such as additional medical costs, care, and past and future loss of earnings. General damages are set by reference to the Personal Injuries Guidelines, which replaced the Book of Quantum on 24 April 2021 and bind both the courts and the Injuries Resolution Board [6].

There is an important honesty point here that competitor pages tend to skip. The Guidelines contain no category called "MRSA." Figures have to be mapped from the closest proxy brackets, the Guidelines' provisions for toxicosis and serious systemic infection, and then adjusted to the individual case. Used that way, the relevant brackets are as follows.

General damages, proxy brackets for a serious bacterial infection (Personal Injuries Guidelines 2021). These are mapped categories, not an MRSA-specific figure. Awards vary case by case.
Severity (proxy classification)Clinical picture that may apply to MRSAGeneral damages bracket
Minor or short-livedDisabling pain, cramps, and disturbance continuing for some days or weeks, with no lasting effects€500 to €6,000
Moderate to seriousIllness needing hospital admission for several days, significant discomfort and fatigue, with full recovery generally expected within about a year€6,000 to €20,000
Severe toxicosis or systemic infectionSerious acute illness requiring admission for weeks, with potential permanent effects€50,000 to €100,000

Two further mechanics matter for realistic expectations. First, MRSA rarely happens in isolation, and usually compounds an existing condition or another error. Where there are multiple injuries, the Guidelines direct the judge to identify the most significant injury, value that bracket, and then uplift the figure so the claimant is fairly compensated for the cumulative effect, rather than simply adding brackets together [6]. Second, where MRSA leads to catastrophic downstream harm, for example brain injury following prolonged low blood pressure and sepsis, the claim is valued under the guidelines for those catastrophic injuries, which run far higher. The overall cap on general damages is €550,000, and special damages are then added on top of whatever general-damages figure applies.

Current as of June 2026, and the figures did not go up. You may have read that the Guidelines amounts rose by 16.7% in 2025. They did not take effect. The Judicial Council approved the proposed increase in January 2025 and sent the draft amendments to the Minister for Justice, who laid them before the Oireachtas in September 2025 but did not bring forward a resolution to approve them. Following the Supreme Court's decision in Delaney v Personal Injuries Assessment Board [2024] IESC 10, any change to the Guidelines requires Oireachtas approval, so without that vote the 2021 figures remain in force [7].

For how these heads of loss are built and evidenced in a clinical claim, see our medical negligence compensation guide. No solicitor can put a reliable figure on a claim before reviewing the medical records, so any number quoted in the abstract is guesswork.

What pushes the value of an MRSA claim is rarely the infection in isolation, but its longer-term consequences, and these are what the special-damages part of a claim is built around. Depending on severity, MRSA can lead to further surgery or wound debridement, prolonged courses of intravenous antibiotics, a much longer hospital stay, permanent scarring or disfigurement, ongoing or recurrent infection, and, in severe systemic cases, amputation or the lasting effects of sepsis. Each of these carries its own financial consequences, such as additional treatment costs, care and assistance, and lost earnings, which are claimed as special damages on top of general damages. Where the consequences are catastrophic, the relevant injury is valued under its own guideline bracket, for example our pages on sepsis and the wider injuries from medical negligence.

Claims of this kind take time. Hospital infection claims in Ireland commonly run from two to five years from first consultation to resolution, with straightforward MRSA cases at the shorter end and contested causation at the longer end. The stage-by-stage timeline is set out in our guide to infection control failures.

How to prove your MRSA was hospital-acquired negligence

Proving an MRSA claim is an exercise in assembling evidence that answers the two questions, breach and causation, before the limitation clock runs out. The building blocks are usually the records, the microbiology, the infection-control documentation, the independent inspection history, and the expert report. The table sets out what each contributes.

Evidence that builds an MRSA hospital negligence claim.
EvidenceWhat it does
Your complete medical recordsRequesting records from an Irish hospital typically takes a couple of months, and they are the foundation for everything else, including the timeline of when MRSA was identified and how it was managed.
Microbiology and swab resultsCulture results, the dates they were taken, and any typing data are central to placing the infection in time and, where possible, matching the strain.
Infection-control and ward recordsScreening logs, isolation and cleaning records, and any ward outbreak surveillance show whether national guidance was followed in practice.
HIQA inspection reportsIndependent reports documenting deficiencies in governance, staffing, or infection control help establish the clinical setting, even though they do not prove your individual case [4].
An independent expert reportA consultant microbiologist or infection-control physician who can address both the standard of care and the source of the infection. Because Ireland's medical community is small, these experts are frequently instructed from outside the jurisdiction.

The earlier this is started, the more of the contemporaneous evidence still exists, and the more of your two-year window remains for the investigation itself, which can easily take several months before anyone can even say whether a viable claim exists.

Quick self-check: could you have an MRSA claim?

This is an educational guide, not legal advice and not an assessment of your case. It does not give a compensation figure or predict the outcome of a claim. It simply reflects the factors a solicitor weighs, using the same breach-and-causation test set out above. Answer the four questions, then speak to a solicitor for advice on your own facts.

MRSA in a nursing home or care setting

MRSA claims are not limited to acute hospitals. Older and frail residents in nursing homes and long-term care are a high-risk group, and the facility owes the same kind of duty to prevent and control infection. The breach questions mirror those in a hospital: whether residents were screened and isolated appropriately, whether wounds and devices were cared for properly, and whether staffing and hygiene were adequate. Independent inspection reports from the Health Information and Quality Authority, which regulates nursing homes, can help establish the conditions in which the infection was acquired [4]. Where the care setting is a nursing home rather than a hospital, the claim is dealt with on the same principles, explained further in our guide to nursing home negligence.

If MRSA contributed to the death of a family member, the position is different again. A death can give rise to a separate claim for the family and the estate, with its own rules and its own two-year limit, set out in our guides to fatal injury claims and who can claim.

What to do next if you think you have a claim

If you or a family member contracted MRSA in an Irish hospital and you are wondering whether it was avoidable, the sensible next step is a conversation, not a commitment. A medical negligence solicitor can listen to what happened, explain whether the two-step test of breach and causation might be met on your facts, and set out what the investigation would involve. Three things help that conversation along.

  • Act on timing. Even if you are unsure when your date of knowledge falls, get advice early. The limitation analysis is exactly the kind of thing that benefits from a professional eye before the window narrows.
  • Keep what you have. Discharge letters, appointment notes, the names of wards and treating teams, and a note of when you were first told about the MRSA all help.
  • Ask about funding. Many medical negligence claims are run on a no-win-no-fee basis. Our no win no fee guide explains how that works and what it does and does not cover.

Common questions about MRSA claims

Can I always claim if I got MRSA in hospital?

No. Catching MRSA in hospital is not automatically negligence. Infections can occur even with good care, and the Supreme Court has confirmed MRSA can be acquired in hospital without any fault. A claim exists only where the infection resulted from a failure in infection-control standards and that failure caused the harm.

Why it matters: it sets realistic expectations before records are reviewed.

Next step: Infection control failures and hospital negligence claims.

How do you prove MRSA was the hospital's fault?

By showing a breach of infection-control duty, measured against the Dunne standard and national HPSC guidance, and proving the breach caused the infection on the balance of probabilities. The causation fight usually turns on whether the MRSA was exogenous (from an external source, such as staff hands) or endogenous (from the patient's own carriage). An independent microbiologist's report, sometimes with genomic strain-matching, is central.

Why it matters: causation, not breach, is where MRSA cases are most often lost.

Next step: Causation in medical negligence.

What is MRSA compensation worth in Ireland?

There is no fixed figure, and the Personal Injuries Guidelines have no specific MRSA category. General damages are mapped from proxy brackets for serious infection, broadly €500 to €6,000 for minor, short-lived illness, €6,000 to €20,000 for moderate cases needing brief admission, and €50,000 to €100,000 for severe toxicosis with potential permanent effects. Special damages for financial losses are added on top. Catastrophic outcomes are valued under higher brackets, up to the €550,000 general-damages cap. Awards vary case by case, and a solicitor cannot value a claim without the medical records.

Why it matters: the proxy mapping is honest about what the Guidelines actually contain.

Next step: Medical negligence compensation.

Is there a time limit for an MRSA claim?

Yes, generally two years, but the start date is the key issue. Under the date-of-knowledge rule, and the MRSA case O'Sullivan v Ireland [2019] IESC 33, the clock may not start until you knew, or reasonably should have known, that the infection was attributable to negligence, which can be later than the infection itself, provided you acted reasonably promptly in getting advice. Do not rely on this without checking your own dates, because waiting is the most common way claims are lost.

Why it matters: infections often surface well after the hospital stay.

Next step: Date of knowledge and time limits.

Does an MRSA claim go through the Injuries Board?

No. Unlike most personal injury claims, medical negligence claims, including MRSA hospital negligence, are not dealt with by the Injuries Resolution Board (IRB). They proceed directly through the courts, and the courts have confirmed it is not appropriate to issue proceedings without a supportive independent expert report.

Why it matters: the process and evidence differ from a standard PI claim.

Next step: Medical negligence claims.

What if I was already carrying MRSA before admission?

Pre-existing colonisation is exactly the issue the defence will raise, and it does make causation harder, although it does not automatically defeat a claim. The microbiologist's task is to distinguish hospital acquisition from carriage or community acquisition, for example through the timing of results and strain typing. Whether a claim is viable depends on what that evidence shows.

Why it matters: many people assume carriage rules them out when it may not.

Next step: Infection control failures.

What are the warning signs of MRSA after surgery?

At a wound, drip, or catheter site, watch for increasing redness, swelling, heat and pain, pus or unusual discharge, a wound that will not heal, and red streaking from the site. Wider signs that the infection has spread include a high temperature and chills, feeling very unwell, breathlessness, a fast heartbeat, and confusion. These need urgent medical attention, and a delay in acting on clear symptoms can itself be part of a claim.

Why it matters: early recognition protects your health and preserves evidence of timing.

Next step: Sepsis from infection.

Is the time limit for an MRSA claim two years or three?

In the Republic of Ireland it is two years from the date of knowledge. The three-year figure you may have seen online is United Kingdom law and does not apply here. A three-year period for clinical negligence actions was provided for by section 221 of the Legal Services Regulation Act 2015, but that clinical-negligence period is conditional on pre-action protocols and has never been commenced, so the limit remains two years. The date of knowledge can fall later than the infection, but you should never assume extra time.

Why it matters: relying on the UK figure can cost you the final year of your deadline.

Next step: Time limits and date of knowledge.

Can I claim for MRSA caught in a nursing home, or if a relative died?

Yes to both, in principle. A nursing home owes the same kind of duty as a hospital to prevent and control infection, and a claim turns on the same questions of breach and causation. If MRSA contributed to a death, the family and the estate may have a separate claim with its own two-year limit. Both routes are assessed on their own facts.

Why it matters: MRSA claims are not limited to acute hospitals or to living claimants.

Next step: Nursing home negligence and fatal injury claims.

References

  1. [1] Courts Service of Ireland, judgments of the Superior Courts (including O'Sullivan v Ireland [2019] IESC 33, Dunne v National Maternity Hospital [1989] IR 91, and Morrissey v HSE [2020] IESC 6). Courts.ie (accessed June 2026).
  2. [2] Health Protection Surveillance Centre, MRSA guidance and surveillance, HSE. HPSC (accessed June 2026).
  3. [3] Health Service Executive, MRSA patient information. HSE.ie (accessed June 2026).
  4. [4] Health Information and Quality Authority, health-service inspection reports. HIQA (accessed June 2026).
  5. [5] Statute of Limitations (Amendment) Act 1991, section 2 (date of knowledge) and section 3(1) (limitation period, as amended through Part 2A of the Civil Liability and Courts Act 2004 and substituted by s.221 of the Legal Services Regulation Act 2015). Irish Statute Book (accessed June 2026).
  6. [6] Injuries Resolution Board, rules and legislation, including the Personal Injuries Guidelines. Injuries.ie (accessed June 2026).
  7. [7] Judicial Council, Personal Injuries Guidelines and amendment status. Judicial Council (accessed June 2026).
  8. [8] Reporting of a four-year MRSA (ST72-MRSA-IV) outbreak in an Irish surgical high-dependency unit linked to healthcare-worker recolonisation, peer-reviewed study via the National Library of Medicine. PMC / NLM (accessed June 2026).
  9. [9] Health Protection Surveillance Centre, EARS-Net antimicrobial resistance data and reports for Ireland (S. aureus / MRSA), 2024 figures published November 2025. HPSC EARS-Net (accessed June 2026).
  10. [10] National Clinical Effectiveness Committee, Department of Health, National Clinical Guideline No. 30: Infection Prevention and Control (published 2023, updated 2025). gov.ie (accessed June 2026).

This information is for educational purposes only and does not constitute legal advice. Every case is different and outcomes vary. Consult a qualified solicitor for advice specific to your situation. Nothing on this page is a prediction of any result. In contentious business, a solicitor may not calculate fees or other charges as a percentage or proportion of any award or settlement. Gary Matthews Solicitors is regulated by the Law Society of Ireland (PC No. S8178).

Gary Matthews Solicitors

Medical negligence solicitors, Dublin

We help people every day of the week (weekends and bank holidays included) that have either been injured or harmed as a result of an accident or have suffered from negligence or malpractice.

Contact us at our Dublin office to get started with your claim today

Gary Matthews Solicitors
Call Us